{"id":137,"date":"2015-08-10T19:52:38","date_gmt":"2015-08-10T17:52:38","guid":{"rendered":"http:\/\/blogs.uct.ac.za\/cancerphd\/?page_id=137"},"modified":"2018-10-03T03:42:16","modified_gmt":"2018-10-03T01:42:16","slug":"member-database","status":"publish","type":"page","link":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/","title":{"rendered":"Program members"},"content":{"rendered":"

Saif Feroz Khan<\/span><\/h2>\n
\n

khnsai002@myuct.ac.za<\/a><\/strong><\/p>\n

\"42551947_10205150157271673_4612200220501999616_n\"<\/a><\/p><\/blockquote>\n

 <\/p>\n

Personal Details<\/span><\/strong><\/p>\n

Saif Feroz Khan is currently undertaking a Masters degree in the laboratory of Professor Sharon Prince in the Division of Cell Biology at the University of Cape Town. He completed his Bachelors and Honours (first class) at the same university but plays an active role in student leadership and sport.<\/p>\n

Current Research Interests<\/span><\/strong><\/p>\n

My Master\u2019s thesis investigates the potential of repurposing current non-cancer FDA-approved drugs towards cancer therapy and looking more specifically at their specificity towards key protein drivers of cancer progression, namely the transcription factor TBX3. From this point we want to validate the drugs in a panel of cancers such as breast and cervical cancer and move these drugs along the drug development pipeline.<\/p>\n

As a concurrent research, I am aiming to establish which establishments in Cape Town make the best burgers.<\/p>\n

Important accomplishments<\/strong><\/span><\/p>\n

I am an NRF innovation scholarship holder as well as a UCT International student scholorship holder. I have given oral presentation at two key conferences, The SASBMB-FASBMB (2018) and Pathcape (2018) with data generated in my first year of my Masters degree.<\/p>\n

Dr Claudine Van De Venter<\/span><\/h2>\n

 <\/p>\n

\"Claudine\"<\/a><\/p><\/blockquote>\n

Personal Details<\/strong><\/span><\/p>\n

Dr Claudine Van De Venter is currently working at the University of Cape Town\u2019s Faculty of Health Science in the Undergraduate Academic Unit. With a BSc in Complementary Health Sciences, a Bachelor of Complementary Medicine (Summa cum laude) and an almost complete Masters in Public Health (Epidemiology & Biostatistics), she is well on her way to her PhD.<\/p>\n

Current Research Interests<\/strong><\/span><\/p>\n

My Master\u2019s thesis investigates pre-natal infant feeding intentions versus post-partum feeding practices in HIV infected women on anti-retroviral therapy. This study was carried out in Gugulethu, Cape Town. My concurrent research is grounded in evidence based, epidemiological studies in Naturopathic and Complementary Medicine. I am currently involved in research relating to dermatology, musculoskeletal disorders, attention deficit disorder and gluten free diets.<\/p>\n

Important accomplishments<\/strong><\/p>\n

I am a reviewer for the BMJ. I am one of nine researchers, competitively chosen in 2016 via an international application process amongst researchers from top tier and Ivy league universities for the Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) International Naturopathy Research Leadership Program Fellowship at the Faculty of Health, University of Technology, Sydney. This collaboration\u2019s recent publications are:<\/p>\n

Identification of the conditions that complementary medicine practitioners recommend gluten free diets for in Australia.<\/p>\n

The diagnostic and clinical management of individuals recommended gluten free diets by complementary medicine practitioners.<\/p>\n

Trish Muzenda<\/span><\/h2>\n

mzntri001@myuct.ac.za<\/a><\/strong><\/p>\n

\"Trish\"<\/a><\/p>\n

Title of project<\/strong>: Breast Cancer Symptom Awareness and Practices among Primary Health Care Providers in Khayelitsha, South Africa<\/p><\/blockquote>\n

Research objectives:<\/strong>\u00a0 To investigate primary health care (PHC) provider understanding and management of breast cancer risk factors, signs and symptoms.<\/p>\n

Research questions<\/strong><\/p>\n

    \n
  1. What is the knowledge amongst Primary Health Care (PHC) providers on breast cancer signs and symptoms as well as risk factors?<\/li>\n
  2. What is their course of action when they suspect a patient has breast cancer?<\/li>\n<\/ol>\n

    Thandeka Hlongwane<\/span><\/h2>\n

    thandeka16h@gmail.com<\/a><\/strong><\/p>\n

    Title of project<\/strong>: Development of EpCAM Based Human Cytolytic Fusion Proteins (hCFP) for Targeted Killing of Triple Negative Breast Cancer (TNBC) Cells<\/p><\/blockquote>\n<\/blockquote>\n

    Hypothesis: <\/strong>EpCAM based hCFP enable targeted killing of heterogeneous triple negative breast cancer cells at high specificities.<\/p>\n

    Specific objectives\u00a0<\/strong><\/p>\n

      \n
    1. To produce and test novel EpCAM\u00a0human\u00a0cytolytic fusion proteins (hCFP)\u00a0\u00a0for specific\u00a0anti-cancer\u00a0activity in TNBC cell culture model, as well as mouse xenograft models.<\/li>\n
    2. To improve the translocation efficiency of previously designed EpCAM based\u00a0hCFP.<\/li>\n<\/ol>\n

      Paul Mambwe\u00a0Chilwesa<\/span><\/h2>\n

      chilwesapc@icloud.com<\/a><\/strong><\/p><\/blockquote>\n

      \"Paul<\/a><\/p>\n

      Title of project<\/strong>: Comparison of the sensitivity of\u00a018<\/sup>F-Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography (18<\/sup>F-FDG PET\/CT) and Conventional Diagnostic Imaging in detecting metastases in Locally Advanced Breast Cancer Staging at Groote Schuur Hospital<\/p><\/blockquote>\n

      Objective:<\/strong> To assess the difference in the sensitivity in detecting metastases between whole-body\u00a018<\/sup>F-FDG PET\/CT and conventional imaging (CI) for staging in participants with locally advanced irresectable invasive ductal carcinoma (IDC) of the breast treated at Groote Schuur Hospital.<\/p>\n

      Ongeziwe Taku<\/span><\/h2>\n

      tkxong001@myuct.ac.za<\/a><\/strong><\/p><\/blockquote>\n

      \"Ongie\"<\/a><\/p><\/blockquote>\n

      Title of project<\/strong>: Human Papillomavirus Prevalence in Women in the Eastern Cape, South Africa and evaluation of hpVIR\u00a0Real-Time PCR Test [Compare the In-House HPV test (hpVIR Real-Time PCR Test) and Commercial HPV Test (Hybrid Capture 2)] for HPV Detection and Cervical Cancer Screening<\/p><\/blockquote>\n

      Specific objectives<\/strong><\/p>\n

        \n
      1. To investigate the prevalence of HPV, risk factors associated with HPV in HIV-positive and HIV negative women.<\/li>\n
      2. To screen for high-risk HPVs in self-collected and clinician collected specimen using real-time hpVIR<\/em> and HC2.<\/li>\n
      3. To compare the performance of real-time hpVIR<\/em> test to HC2 test on clinician-collected specimens.<\/li>\n<\/ol>\n

        Marc Hendrinks<\/span><\/h2>\n

        marc.hendricks@uct.ac.za<\/a><\/strong><\/p>\n

        Title of project<\/strong>: Teratomas, Malignant Extracranial Germ Cell Tumours (MEGCTs) and Sex Cord Stromal Tumours (SCSTs) in Children: Moving Towards a Standardised National South African Treatment Approach<\/p><\/blockquote>\n

        Research questions\/Specific objectives:<\/strong><\/p>\n

          \n
        1. What is the survival of children with teratomas, malignant germ cell tumours (which occur outside the brain) and sex cord stromal tumours treated who are treated on a standardised national regimen?<\/li>\n
        2. Are there any additional factors which influence survival, for example, age, sex, primary site of the tumour, nutritional status (whether children are malnourished or not) and socio-economic status?<\/li>\n
        3. Are there any treatment related complications which affect survival or quality of life of patients treated on a standardised regimen?<\/li>\n
        4. Are there any long term chemotherapy related effects like deafness or kidney problems which may arise following treatment with a standardised chemotherapy regimen?<\/li>\n
        5. What are there long term endocrine effects?<\/li>\n<\/ol>\n

          Rakiya Saidu<\/span><\/h2>\n

          rakiyasaid@gmail.com<\/a><\/strong><\/p><\/blockquote>\n

          Awaiting project information<\/p>\n

          Fleury A. N. Biteghe<\/strong><\/span><\/h2>\n

          fleurinha@hotmail.com<\/a><\/strong><\/p><\/blockquote>\n

          \"Fleury\"<\/a><\/p>\n

          Title of project<\/strong>: Overcoming Chemoresistance in Melanoma using Combination Therapy Treatment<\/p><\/blockquote>\n

          Introduction:<\/strong> Metastatic melanoma is the deadliest form of skin cancer, which is highly resistant to chemotherapeutic treatment. The central players in this mechanism are said to be the ATP-Binding cassette (ABC) transporter proteins, which are overexpressed in chemoresistant melanoma cells, hence lower the accumulation of cytotoxic drugs within the cells. This study set out to investigate using an in vitro model of metastatic melanoma cells, the mechanisms underlying chemoresistance and the efficacy of adjunctive combination therapy treatment (photodynamic therapy + chemotherapy) in an attempt to decrease cellular resistance.<\/p>\n

          Objectives<\/strong><\/p>\n

            \n
          1. Assess cell viability and clonogenicity after the different therapeutic treatments on melanoma cells<\/li>\n
          2. Determine the expression of the ABC transporters before and after therapeutic treatments<\/li>\n
          3. Investigate the role of PI3k\/Akt pathway in controlling melanoma resistance<\/li>\n<\/ol>\n

            Augustine Musyoka<\/strong><\/span><\/h2>\n

            muisyoam@yahoo.com<\/a><\/strong><\/p><\/blockquote>\n

            \"Augustine\"<\/a><\/p>\n

            Title of project<\/strong>: The Use of MAGE-C1 Expression in the monitoring and treatment of autologous transplant patients with multiple myeloma<\/p><\/blockquote>\n

            Aim:<\/span><\/b>\u00a0To investigate the use MAGE-C1 expression in monitoring ASCT patients for relapse, and also strive to improve treatment outcomes by purging premalignant from the stem-cell harvest bags prior to transplant.<\/span><\/p>\n

            Objectives<\/strong><\/p>\n

              \n
            1. Understand the expression of MAGE-C1 in the population using flow cytometry.<\/li>\n
            2. Monitoring of autologous stem cell transplant MM patients during transplantation process using flow cytometry.<\/li>\n
            3. Development and assessment of a sensitive RT-qPCR MAGE-C1 assay for use in monitoring autologous stem cell transplant patients.<\/li>\n
            4. Investigate the localization of MAGE-C1 on B-cells using\u00a0immunofluorescence\u00a0staining<\/li>\n
            5. Develop\u00a0MACS-bead\u00a0methodology to investigate the possibility of removing the malignant MAGE-C1 positive cells from the stem cell collection prior to re-transplantation.<\/li>\n<\/ol>\n

              Christabel Abewe<\/strong><\/span><\/h2>\n

              abewec@gmail.com<\/a><\/strong><\/p>\n

              \"Abewe\"<\/a><\/p>\n

              Title of project<\/strong>: Universal Public Finance for Early Detection of Breast Cancer in Low- and Middle-Income Countries<\/p><\/blockquote>\n

              Research question<\/strong>: The purpose of this study is to apply the extended cost-effectiveness analysis (ECEA) method to evaluate the consequences of publically funding interventions for early detection of breast cancer in one low-income country (Uganda) and one middle-income country (South Africa).<\/p>\n

              Study objectives <\/strong><\/p>\n

                \n
              1. To estimate the cost of various early detection methods for breast cancer.<\/li>\n
              2. Using effectiveness data for each early detection method — estimate incremental cost effectiveness ratios (ICER), e.g. cost per disease averted or life saved.<\/li>\n
              3. Assess the level and distribution of the burden of disease averted (lives saved) across wealth quintiles.<\/li>\n
              4. Evaluate the financial protection (household expenditure averted) provided by UPF for early detection of breast cancer across different socioeconomic strata.<\/li>\n<\/ol>\n

                Alltallents Murawa<\/strong><\/span><\/h2>\n

                atmurahwa@gmail.com<\/a><\/strong><\/p><\/blockquote>\n

                \"ATM\"<\/a><\/p>\n

                Title of project<\/strong>: Characterization of Novel Genital Human Papillomaviruses in HIV-1 Concordant and Discordant Heterosexual Couples<\/p><\/blockquote>\n

                Introduction:<\/strong> The recognition of a novel HPV type by the HPV reference centre and the scientific community is based on availability of the full cloned genome, with the L1 gene sequence greater than 10% different or <90% similar from any previously described type. On observation of a potential novel HPV type, it has to be amplified to the complete genome, cloned into a vector system, sequenced, submitted for official naming, classified into the correct phylogenetic position and have its genes annotated. Determination of sequence similarity and differences requires a rigorous interrogation of the potential HPV type with sequences of all other HPV types in various databases.<\/p>\n

                Objectives<\/strong><\/p>\n

                  \n
                1. To clone and sequence for characterisation of potential novel HPVs from penile samples.<\/li>\n
                2. To establish the prevalence of Beta- and Gamma papillomaviruses in female genital samples.<\/li>\n
                3. To compare HPVs among the heterosexual couples and their association with multiple HPV infection and sharing of viruses in couples.<\/li>\n
                4. To establish the association between genital Beta and Gamma papillomavirus infection with HIV infection status, CD4 counts and abnormal cervical cytology in heterosexual couples.<\/li>\n<\/ol>\n

                  Harris Onywera<\/strong><\/span><\/h2>\n

                  do79harris@gmail.com<\/a><\/strong><\/p>\n

                  \"Harris\"<\/a><\/p>\n

                  Title of project<\/strong>: A Study of the Genital Microbiotas of Black South African Women and Men: Associations with Human Papillomavirus and HIV Infections<\/p><\/blockquote>\n

                  Objectives<\/strong>: To define the composition, diversity, and potential function of cervicovaginal\u00a0and penile microbiotas\u00a0of heterosexual Black South African women and men and further identify specific bacteria associated with HPV and HIV infections.<\/p>\n

                  Research techniques used<\/strong>: DNA extraction, purification, and quantification; PCR; Deep sequencing (Ion Torrent PGM and Illumina MiSeq); Bioinformatics analysis pipelines (QIIME\/UPARSE and mothur); LefSe for biomarkers\u00a0discovery; STAMP for detecting biologically active bacteria; R package (MetagenomeSeq, Phyloseq).<\/p>\n

                  Muneerah Smith <\/strong><\/span><\/h1>\n

                  muneerah.smith@gmail.com<\/a><\/strong><\/p><\/blockquote>\n

                  \"Muneerha<\/a><\/p>\n

                  Title of project:\u00a0<\/strong>Using an Immunoproteomic Approach to Identify diagnostic and Prognostic Markers of Collorectal\u00a0Cancer<\/p><\/blockquote>\n

                   <\/p>\n

                  Objectives<\/strong>:\u00a0Isolate cancer specific antigens using native protein microarrays; Identify isolated cancer specific antigens by mass spectrometry; Determine which antigens are best for cancer diagnostis and prognostis; Test the validity of antigens for use in cancer cohorts; Incorporate novel antigens markers into the already established CT100+ microarray<\/p>\n

                  Research techniques used<\/strong>: Immunoprecipitation; Native protein extraction from CRC tissue samples; IgG biotinyaltion; Fast protein liquid chromoatography (FPLC); Isoelectric focussing\/ion exchange chromatography; Create native protein microarray; Mass spectrometry.<\/p>\n

                  Tracey Adams<\/strong><\/span><\/h2>\n

                  tracey.adams@uct.ac.za<\/a><\/strong><\/p>\n

                  \"T<\/a>Title of project :\u00a0<\/strong>Is There\u00a0 a Difference among \u00a0Women\u00a0 of\u00a0 African \u00a0Heritage \u00a0Compared\u00a0 to \u00a0Women with European or Mixed \u00a0Race Heritage in Terms of the Genetic \u00a0Profile\u00a0 in Women Diagnosed\u00a0 with Ovarian \u00a0Cancer?<\/p><\/blockquote>\n

                  Objectives<\/strong>: Retrospectively analyse paraffin embedded tumour tissue of patients diagnosed with epithelial ovarian cancer in our database; Prospectively identify for predisposing germ line mutations in patients diagnosed with ovarian cancer; Test blood samples of patients who present with ovarian masses prior to surgery or histological diagnosis; Analyse the molecular pathology in ovarian tumour samples of the ovarian cancer patients identified.<\/p>\n

                  Research techniques used:<\/strong>DNA analysis ( next generation sequencing) from blood samples to evaluate BRCA ( germline) mutations; Tumour tissue analysis via TMA\u2019s (tissue micro-arrays); Molecular pathology \u00a0using IHC (immunohistochemistry) on tissue micro-arrays (TMA\u2019s).<\/p>\n

                  Serah Kimani<\/strong><\/span><\/h2>\n

                  swkimani@gmail.com<\/a><\/strong><\/p><\/blockquote>\n

                  \"Serah<\/a><\/p>\n

                   <\/p>\n

                  Title of project: <\/strong>Potential Inhibitors for Oncogenic Transcription Factors, TBX2 and TBX3<\/p><\/blockquote>\n

                   <\/p>\n

                  Objectives<\/strong>:The focus is on characterizing two proteins, TBX2 and TBX3, whose levels are frequently elevated in several cancers and leads to the development and progression of cancer. They have been identified as drug targets for anti-cancer therapies. We seek to develop small molecule compounds that may be used as drugs to inhibit their activity, thereby contributing to more effective anti-cancer therapies.<\/p>\n

                  \u00a0Henry Adeola\u00a0<\/strong><\/span><\/h2>\n

                  henry.adeola@uct.ac.za<\/a><\/strong><\/p>\n

                  \"Adeola<\/a><\/strong><\/p>\n

                   <\/p>\n

                  Title of project:<\/strong>\u00a0Novel Biomarkers of Prostate Cancer using Proteomics and Lipidomics techniques<\/p><\/blockquote>\n

                   <\/p>\n

                  Objectives<\/strong>: Biomarker discovery in urine, serum and prostatectomy\u00a0tissue; Proteome and Lipidome establishment for SA cohort; Development of point of care panel of prostate cancer diagnostic biomarkers\u00a0in SA Mass Spectrometry<\/p>\n

                  Research techniques used:<\/strong>\u00a0Protein microarray; Gel-based chromatography; Ultra high performance liquid chromatography (UHPLC); Filter aided sample preparation (FASP)<\/p>\n

                  Ramadhan<\/span>\u00a0i Salum Chambuso<\/span><\/h1>\n

                  CHMRAM001@myuct.ac.za<\/a><\/strong><\/span><\/p>\n

                  \"RAMADHANI\"<\/a><\/p>\n

                   <\/p>\n

                  Title of project<\/strong>: \u00a0HIV\/HPV co-infection and host genetics of cervical cancer study<\/p><\/blockquote>\n

                   <\/p>\n

                  Objectives<\/strong><\/p>\n

                  1. To characterize the HIV\/HPV co-infection status according to the age difference<\/p>\n

                  Hypothesis<\/strong>; Women with HIV\/HPV co-infection present with invasive cervical cancer at younger age than HPV only infected women.<\/p>\n

                  2. To compare the prevalence of HPV infection in HIV positive women.<\/p>\n

                  Hypothesis<\/strong>; HIV infected women are more likely to be infected with multiple strains of high risk HPV than HIV negative women.<\/p>\n

                  3. To classify the HLA-II genes according to HIV\/HPV status<\/p>\n

                  Hypothesis; <\/strong>Women with HIV\/HPV co-infection are more likely to have high risk HLA class II patterns compared to HIV uninfected women, therefore, will lead to early development of invasive cervical cancer.<\/p>\n

                  4. To characterize the severity of LOH on chromosome 6 between HIV positive and HIV negative women.<\/p>\n

                  Hypothesis; <\/strong>Women infected with HIV express high frequency of LOH on chromosome 6 compared to HIV negative women. LOH is the most common genetic alteration occurred in human carcinogenesis process, which implies the absence of a whole functional\u00a0tumor suppressor gene to protect the body.<\/p>\n

                  Lamech Mwapagha<\/span><\/h2>\n

                  lmwapa@gmail.com<\/a><\/strong><\/p><\/blockquote>\n

                  Awaiting project information<\/p>\n

                  Lindiwe Lamola<\/span><\/h2>\n

                  lindie.lamola@gmail.com<\/strong><\/span><\/p><\/blockquote>\n

                  Awaiting project information<\/p>\n

                  Aderonke Ajayi-Smith<\/strong><\/span><\/h2>\n

                  ajayismithaf@yahoo.com<\/strong><\/span><\/p>\n

                  Alexis Joy Neumann<\/strong><\/h1>\n

                  NMNALE001@myuct.ac.za<\/a><\/strong><\/p><\/blockquote>\n

                  Awaiting project information<\/p>\n

                  Anna Vorster<\/strong><\/h2>\n

                  anna.vorster@uct.ac.za<\/a><\/strong><\/p><\/blockquote>\n

                  Awaiting project information<\/p>\n

                  Horacia Naidoo<\/strong><\/h2>\n

                  NDXHOR001@myuct.ac.za<\/a><\/strong><\/p><\/blockquote>\n

                  Awaiting project information<\/p>\n

                  Jade Peres<\/strong><\/h2>\n

                  monralf@yahoo.com<\/a><\/strong><\/p><\/blockquote>\n

                  Awaiting project information<\/p>\n

                  <\/h2>\n

                  Rehana Omar<\/strong><\/h2>\n

                  rehanaomar@yahoo.com<\/a><\/strong><\/p><\/blockquote>\n

                  Awaiting project information<\/p>\n

                  \u00a0<\/em>Sylvester Omoruyi<\/strong><\/h2>\n

                  3405455@myuwc.ac.za<\/a><\/strong><\/p><\/blockquote>\n<\/blockquote>\n

                  Awaiting project information<\/p>\n","protected":false},"excerpt":{"rendered":"

                  Saif Feroz Khan khnsai002@myuct.ac.za   Personal Details Saif Feroz Khan is currently undertaking a Masters degree in the laboratory of Professor Sharon Prince in the Division of Cell Biology at … Continue reading Program members<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"ngg_post_thumbnail":0,"footnotes":""},"yoast_head":"\nProgram members - Postgraduate Cancer Research Initiative (CRI) blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Program members - Postgraduate Cancer Research Initiative (CRI) blog\" \/>\n<meta property=\"og:description\" content=\"Saif Feroz Khan khnsai002@myuct.ac.za   Personal Details Saif Feroz Khan is currently undertaking a Masters degree in the laboratory of Professor Sharon Prince in the Division of Cell Biology at … Continue reading Program members →\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/\" \/>\n<meta property=\"og:site_name\" content=\"Postgraduate Cancer Research Initiative (CRI) blog\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-03T01:42:16+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/blogs.uct.ac.za\/cancerphd\/wp-content\/uploads\/2015\/08\/42551947_10205150157271673_4612200220501999616_n-300x300.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/\",\"url\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/\",\"name\":\"Program members - Postgraduate Cancer Research Initiative (CRI) blog\",\"isPartOf\":{\"@id\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/blogs.uct.ac.za\/cancerphd\/wp-content\/uploads\/2015\/08\/42551947_10205150157271673_4612200220501999616_n-300x300.jpg\",\"datePublished\":\"2015-08-10T17:52:38+00:00\",\"dateModified\":\"2018-10-03T01:42:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#primaryimage\",\"url\":\"http:\/\/blogs.uct.ac.za\/cancerphd\/wp-content\/uploads\/2015\/08\/42551947_10205150157271673_4612200220501999616_n-300x300.jpg\",\"contentUrl\":\"http:\/\/blogs.uct.ac.za\/cancerphd\/wp-content\/uploads\/2015\/08\/42551947_10205150157271673_4612200220501999616_n-300x300.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Program members\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/#website\",\"url\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/\",\"name\":\"Postgraduate Cancer Research Initiative (CRI) blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blogs.uct.ac.za\/cancerphd\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Program members - Postgraduate Cancer Research Initiative (CRI) blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/","og_locale":"en_GB","og_type":"article","og_title":"Program members - Postgraduate Cancer Research Initiative (CRI) blog","og_description":"Saif Feroz Khan khnsai002@myuct.ac.za   Personal Details Saif Feroz Khan is currently undertaking a Masters degree in the laboratory of Professor Sharon Prince in the Division of Cell Biology at … Continue reading Program members →","og_url":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/","og_site_name":"Postgraduate Cancer Research Initiative (CRI) blog","article_modified_time":"2018-10-03T01:42:16+00:00","og_image":[{"url":"http:\/\/blogs.uct.ac.za\/cancerphd\/wp-content\/uploads\/2015\/08\/42551947_10205150157271673_4612200220501999616_n-300x300.jpg"}],"twitter_misc":{"Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/","url":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/","name":"Program members - Postgraduate Cancer Research Initiative (CRI) blog","isPartOf":{"@id":"https:\/\/blogs.uct.ac.za\/cancerphd\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#primaryimage"},"image":{"@id":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#primaryimage"},"thumbnailUrl":"http:\/\/blogs.uct.ac.za\/cancerphd\/wp-content\/uploads\/2015\/08\/42551947_10205150157271673_4612200220501999616_n-300x300.jpg","datePublished":"2015-08-10T17:52:38+00:00","dateModified":"2018-10-03T01:42:16+00:00","breadcrumb":{"@id":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#primaryimage","url":"http:\/\/blogs.uct.ac.za\/cancerphd\/wp-content\/uploads\/2015\/08\/42551947_10205150157271673_4612200220501999616_n-300x300.jpg","contentUrl":"http:\/\/blogs.uct.ac.za\/cancerphd\/wp-content\/uploads\/2015\/08\/42551947_10205150157271673_4612200220501999616_n-300x300.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.uct.ac.za\/cancerphd\/member-database\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.uct.ac.za\/cancerphd\/"},{"@type":"ListItem","position":2,"name":"Program members"}]},{"@type":"WebSite","@id":"https:\/\/blogs.uct.ac.za\/cancerphd\/#website","url":"https:\/\/blogs.uct.ac.za\/cancerphd\/","name":"Postgraduate Cancer Research Initiative (CRI) blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.uct.ac.za\/cancerphd\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/blogs.uct.ac.za\/cancerphd\/wp-json\/wp\/v2\/pages\/137"}],"collection":[{"href":"https:\/\/blogs.uct.ac.za\/cancerphd\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/blogs.uct.ac.za\/cancerphd\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.uct.ac.za\/cancerphd\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.uct.ac.za\/cancerphd\/wp-json\/wp\/v2\/comments?post=137"}],"version-history":[{"count":43,"href":"https:\/\/blogs.uct.ac.za\/cancerphd\/wp-json\/wp\/v2\/pages\/137\/revisions"}],"predecessor-version":[{"id":726,"href":"https:\/\/blogs.uct.ac.za\/cancerphd\/wp-json\/wp\/v2\/pages\/137\/revisions\/726"}],"wp:attachment":[{"href":"https:\/\/blogs.uct.ac.za\/cancerphd\/wp-json\/wp\/v2\/media?parent=137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}